Table 1.
Demographics of pediatric relapsing-remitting MS and healthy control subjects
| Clinical Information | MS | Controls | |
|---|---|---|---|
|
| |||
| Relapse (n=14) | Remission (n=26) | (n=11) | |
|
| |||
| Age Range* | 8.88–20.76 | 11.5–19.54 | 5.96–19.28 |
|
| |||
| Mean Age* ± SD | 15.28 ± 3.30 | 16.38 ± 1.94 | 13.76 ± 3.37 |
|
| |||
| Gender | 10 female | 21 female | 5 female |
| 4 male | 5 male | 6 male | |
|
| |||
| Race | 7 white | 18 white | 5 white |
| 7 black | 8 black | 5 black 1 not reported |
|
|
| |||
| Steroids | 3 Yes | 1 Yes | 11 No |
| 11 No | 25 No | ||
|
| |||
| Disease-Modifying Agents | |||
| Copaxone | 2 | 6 | None |
| Rebif | 3 | 6 | None |
| Avonex | 2 | 3 | None |
| Betaseron | 0 | 1 | None |
| Extavia | 0 | 1 | None |
| None | 7 | 9 | None |
|
| |||
| Age at symptom onset Range* | 6.56–17.62 | 7.76–17.35 | N/A |
|
| |||
| Mean Age at symptom Onset* ± SD | 13.54 ± 3.41 | 14.21 ± 2.38 | N/A |
|
| |||
| Disease Duration* | 1.74 ± 1.82 | 2.17 ± 2.11 | N/A |
*
Age is represented in years